ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.19 HKD | 0.00% |
|
+5.25% | -24.29% |
| Apr. 03 | Alibaba Health Refutes Rumors of Purchase of Telemedicine Platform HaoDF | MT |
| Mar. 28 | Alibaba Health Information Technology Limited and Alibaba.com Enter Shared Services Agreement | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 28.51B 3.94B 30.79B | Sales 2025 * | 33.31B 4.61B 35.98B | Capitalization | 47.49B 6.57B 51.3B |
|---|---|---|---|---|---|
| Net income 2024 * | 766M 106M 827M | Net income 2025 * | 1.14B 157M 1.23B | EV / Sales 2024 * | 1.28 x |
| Net cash position 2024 * | 10.91B 1.51B 11.79B | Net cash position 2025 * | 12.46B 1.72B 13.46B | EV / Sales 2025 * | 1.05 x |
| P/E ratio 2024 * |
55.8
x | P/E ratio 2025 * |
36.7
x | Employees | 1,547 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 37.22% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
More news
| 1 day | +0.63% | ||
| 1 week | -2.74% | ||
| Current month | +7.77% | ||
| 1 month | +16.00% | ||
| 3 months | +1.59% | ||
| 6 months | -32.42% | ||
| Current year | -24.76% |
1 week
2.98
3.24
1 month
2.593.43
Current year
2.594.30
1 year
2.595.82
3 years
2.5922.10
5 years
2.5930.15
10 years
2.5930.15
| Managers | Title | Age | Since |
|---|---|---|---|
Di Fan Shen
CEO | Chief Executive Officer | 46 | - |
Yan Wu Tu
DFI | Director of Finance/CFO | 46 | 19-08-31 |
Shun Yan Zhu
CHM | Chairman | 53 | 20-03-15 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yi Hong Wu
BRD | Director/Board Member | 56 | 23-08-10 |
Shun Yan Zhu
CHM | Chairman | 53 | 20-03-15 |
Rong Shao
BRD | Director/Board Member | 62 | 23-08-10 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.59% | 293 M€ | +17.47% | - | |
| 1.56% | 88 M€ | +16.09% | - | |
| 1.56% | 11 M€ | +14.93% | - | |
| 1.42% | 0 M€ | 0.00% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-14 | 3.19 | 0.00% | 36 674 861 |
| 24-05-13 | 3.19 | +0.63% | 34,234,250 |
| 24-05-10 | 3.17 | 0.00% | 44,077,550 |
| 24-05-09 | 3.17 | +3.59% | 60,638,310 |
| 24-05-08 | 3.06 | +0.33% | 58,943,130 |
Delayed Quote Hong Kong S.E., May 13, 2024 at 04:08 am EDT
More quotes
Alibaba Health Information Technology Limited is specialized in the direct sale of pharmaceuticals. The turnover is divided across the following activities:
- direct sale of pharmaceuticals (85.2%);
- online sale of pharmaceuticals(12.7%);
- direct healthcare services (1.8%);
- online healthcare services and monitoring of pharmaceuticals (0.3%).
The turnover is divided into the revenue sources of product sales (80.8%) and services (19.2%).
The geographical breakdown of the turnover is as follows: mainland China (95.8%) and Hong Kong (4.2%).
Sector
Drug Retailers
Calendar
2024-05-22
- Q4 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
19
Last Close Price
2.953
CNY
Average target price
5.094
CNY
Spread / Average Target
+72.50%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -24.76% | 6.52B | |
| -22.12% | 12.04B | |
| +15.41% | 6.44B | |
| -9.27% | 6.15B | |
| -2.48% | 4.63B | |
| +60.00% | 4.62B | |
| -6.67% | 3.93B | |
| -10.60% | 3.49B | |
| -6.69% | 3.05B | |
| -8.74% | 2.69B |
- Stock Market
- Equities
- 241 Stock